Form 4: Quest Diagnostics Executive Sam Samad Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
Executive Vice President & CFO of Quest Diagnostics, Sam Samad, reports disposing of shares to cover tax withholding obligations from vesting restricted stock units.
Summary
- On February 26, 2025, Sam Samad, Executive Vice President & CFO of Quest Diagnostics, disposed of 869 shares of common stock.
- The transaction was executed to cover tax withholding obligations arising from the vesting of restricted stock units.
- The price per share was $171.75.
- Following the transaction, Samad directly owns 20,177 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. This transaction is related to tax obligations, which is a common occurrence when restricted stock units vest.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Date of stock disposal transaction |
| 02/28/2025 | Date of signature by Attorney in Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.